GzB-IL18 promotes anti-tumor activity and myeloid cell reGzB-IL18 promotes anti-tumor activity and myeloid reprogramming without causing CAR-T cell-mediated cytokine release syndrome (59). This evidence concerns the gene IL18 and neoplasm.